Joint Formulary & PAD

Vitamin B compound - All indications

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Non Formulary
Formulations :
  • Tablets
Associated Icons :
SPC
Restrictions / Comments :
Important

NICE no longer recomennd Vitamin B compound for the prevention of Wernicke's encephalopathy 

PAD Profile

ChemicalSubstance :
Vitamin B compound
Indication :
All indications
Group Name :
Keywords :
vit B Co, vitamin B compound, vitamin B Co, vitamin B complex
Brand Names Include :
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
2

Other Indications

Below are listed other indications that Vitamin B compound is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat All indications.

Committee Recommendations (2)

The Surrey and North West Sussex Area Prescribing Committee does not recommend the use of vitamin B compound tablets and they will be considered Non Fomulary on the traffic light system
Current prescribing of vitamin B compound tablets should be reviewed (in line with the RMOC position statement document below). Patients should be checked for ongoing medical indication for prescribing and if there is a need to continue treatment, the patient should be switched to vitamin B compound strong tablets.

Note: vitamin B compound strong tablets are non-formulary for use in alcohol dependence (Profile : Vitamin B Compound strong - Alcohol dependence (res-systems.net)) but may be appropriate in refeeding syndrome (Profile : Vitamin B Compound strong - Refeeding syndrome (res-systems.net))

At the Surrey and North-West Sussex Area Prescribing Committee (APC) held in June 2020, it was decided that all BLACK status drugs would have their review dates extended for 5 years without the need for a review.

If a clinician or provider wishes to change the traffic light status of any BLACK drug then they will need to submit a paper for change as per usual APC process.